Comparison results
| Results: Differences General | ✘Subclavian theft syndrome | ✘Ischemic neuropathy of the optic nerve | |||||||
| Related research | Analogs | Analogs | |||||||
| |||||||||
| Distinctive symptoms | |||||||||
| Register, to see more distinctive signs of diseases and studies | 100% | — | |||||||
| Register, to see more distinctive signs of diseases and studies | — | 100% | |||||||
| subclavian theft syndrome | 93% | — | |||||||
| increased | — | 99% | |||||||
| cervical migraine | 49% | — | |||||||
| angiopathy | — | 92% | |||||||
| arterial occlusion | 48% | — | |||||||
| leukocytosis | — | 85% | |||||||
| takayasu's disease | 44% | — | |||||||
| wedge-shaped defect | — | 83% | |||||||
| stair muscle syndrome | 43% | — | |||||||
| anemia | — | 80% | |||||||
| congenital syphilis | 42% | — | |||||||
| scotoma | — | 79% | |||||||
| neck ribs | 42% | — | |||||||
| loss of visual fields | — | 74% | |||||||
| consequences of stroke | 36% | — | |||||||
| absolute neutrophilia | — | 66% | |||||||
| obliterating atherosclerosis | 36% | — | |||||||
| giant cell arteritis | — | 63% | |||||||
| pre-fainting condition | 34% | — | |||||||
| horton's disease | — | 58% | |||||||
| transient ischemic attack | 34% | — | |||||||
| acute coronary syndrome | — | 56% | |||||||
| weakness in the extremities | 32% | — | |||||||
| neurological disorders | — | 56% | |||||||
| ataxia | 30% | — | |||||||
| pale optic discs | — | 54% | |||||||
| syphilis | 30% | — | |||||||
| CHD | — | 53% | |||||||
| stroke | 28% | — | |||||||
| ocular ischemic syndrome | — | 52% | |||||||
| impaired coordination | 28% | — | |||||||
| sharpness decreased vision | — | 51% | |||||||
| dizziness | 27% | — | |||||||
| angina pectoris | — | 51% | |||||||
| muscle weakness | 26% | — | |||||||
| blindness | — | 51% | |||||||
| imbalance | 25% | — | |||||||
| heart dysfunction | — | 48% | |||||||
| weakness after illness | 25% | — | |||||||
| increased pressure under stress | — | 45% | |||||||
| angioplasty | 23% | — | |||||||
| acute condition | — | 45% | |||||||
| lowered | 22% | — | |||||||
| rheumatic polymyalgia | — | 43% | |||||||
| impaired arterial function | 41% | 33% | |||||||
| neurological pain | — | 43% | |||||||
| rheumatic muscle pain | — | 42% | |||||||
| transient blindness | — | 42% | |||||||
| atheroma | — | 41% | |||||||
| soft tissue rheumatism | — | 41% | |||||||
| atherosclerosis of the carotid arteries | — | 40% | |||||||
| pain in the eyes | — | 40% | |||||||
| trypanosomiasis | — | 40% | |||||||
| essential hypertension | — | 39% | |||||||
| blurred vision | 29% | 66% | |||||||
| ischemic neuropathy of the optic nerve | — | 37% | |||||||
| changes in the blood | — | 37% | |||||||
| common arterial trunk | — | 37% | |||||||
| systemic vasculitis | — | 36% | |||||||
| headaches | — | 36% | |||||||
| periodic headaches | — | 36% | |||||||
| headache behind the eyes | — | 35% | |||||||
| up circulatory disorders | — | 35% | |||||||
| hypertension | — | 35% | |||||||
| rheumatic inflammation | — | 35% | |||||||
| atherosclerosis of the aorta | — | 35% | |||||||
| He's been ill for a long time | — | 34% | |||||||
| swelling | — | 34% | |||||||
| optic nerve atrophy | — | 34% | |||||||
| visual impairment | 27% | 61% | |||||||
| rheumatism | — | 33% | |||||||
| angiopathy of the retina | — | 32% | |||||||
| arterial bleeding | — | 31% | |||||||
| hypotension | — | 30% | |||||||
| clear boundaries | — | 30% | |||||||
| up vascular mesh | — | 29% | |||||||
| painful appearance | — | 29% | |||||||
| illness from stress | — | 29% | |||||||
| muscle pain | — | 28% | |||||||
| hypotension | — | 26% | |||||||
| diabetes mellitus | — | 26% | |||||||
| thrombosis | — | 26% | |||||||
| stress | — | 26% | |||||||
| bleeding | — | 25% | |||||||
| impaired venous function | — | 25% | |||||||
| patient's condition | — | 22% | |||||||
| vasculitis | 31% | 45% | |||||||
| atherosclerosis of blood vessels | 29% | 41% | |||||||
| inflammation | 22% | 31% | |||||||
| blood diseases | 23% | 32% | |||||||
| hemianopsia | 39% | 39% | |||||||
Instructions
Video
|